Vetherapy

San Francisco, United States Founded: 2015 • Age: 11 yrs
Provider of stem cell therapies for pets

About Vetherapy

Vetherapy is a company based in San Francisco (United States) founded in 2015 by Pedro Carvalho and Fernanda Berti.. Vetherapy has raised $250 thousand across 3 funding rounds from investors including European Union, EIC Fund and IndieBio. Vetherapy offers products and services including Wound Healing Hydrogel, Stem Cells, and Stem Cell-derived solutions. Vetherapy operates in a competitive market with competitors including Gallant, eQcell, Bioceltix, RevaTis and J-ARM, among others.

  • Headquarter San Francisco, United States
  • Founders Pedro Carvalho, Fernanda Berti
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Veterinary & Animal Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $250 K (USD)

    in 3 rounds

  • Latest Funding Round
    $54.68 K (USD), Grant

    Sep 30, 2019

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Vetherapy

Vetherapy offers a comprehensive portfolio of products and services, including Wound Healing Hydrogel, Stem Cells, and Stem Cell-derived solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Hydrogel for accelerating wound healing in pets using stem cells.

Stem cell treatments for complex diseases in pets.

Derived therapies for various pet health challenges.

People of Vetherapy
Headcount 1-10
Employee Profiles 3
Employee Profiles
People
Pedro Carvalho
Founder & CEO
People
Fernanda Vieira Berti
Co-Founder & CSO
People
Alessandra Zonari
CTO

Unlock access to complete

Teams

Funding Insights of Vetherapy

Vetherapy has successfully raised a total of $250K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $54.68 thousand completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $54,684
  • First Round

    (10 Jan 2018)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2019 Amount Grant - Vetherapy Valuation

investors

May, 2019 Amount Grant - Vetherapy Valuation

investors

Jan, 2018 Amount Seed - Vetherapy Valuation IndieBio
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Vetherapy

Vetherapy has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and IndieBio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Biotech startups are accelerated through IndieBio's focused programs.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Vetherapy

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Vetherapy

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Vetherapy Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Vetherapy

Vetherapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gallant, eQcell, Bioceltix, RevaTis and J-ARM, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Stem cell storage for canine regenerative therapy is offered.
domain founded_year HQ Location
Stem cell therapies for animal health are developed.
domain founded_year HQ Location
Developer of drugs for veterinary therapy
domain founded_year HQ Location
Undifferentiated muscle-derived stem cells are obtained via patented micro-biopsy technology.
domain founded_year HQ Location
Developer of lymphocyte therapy and stem cell therapy for dogs and cats
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Vetherapy

Frequently Asked Questions about Vetherapy

When was Vetherapy founded?

Vetherapy was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Where is Vetherapy located?

Vetherapy is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Who is the current CEO of Vetherapy?

Pedro Carvalho is the current CEO of Vetherapy. They have also founded this company.

Is Vetherapy a funded company?

Vetherapy is a funded company, having raised a total of $250K across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Jan 10, 2018.

What does Vetherapy do?

VR therapy is developing stem cell therapies for pets. The company is focused on inflammatory, auto-immune and neurologic diseases. The company provides stem cells for dogs, cats, and horses. The company has patented wound healing hydrogel, based on stem cell secretome, that helps in the regeneration of all the layers of the skin. The company has stem cell-derived solutions in the form of eye-drops and plasma solutions.

Who are the top competitors of Vetherapy?

Vetherapy's top competitors include Gallant, Bioceltix and eQcell.

What products or services does Vetherapy offer?

Vetherapy offers Wound Healing Hydrogel, Stem Cells, and Stem Cell-derived solutions.

Who are Vetherapy's investors?

Vetherapy has 3 investors. Key investors include European Union, EIC Fund, and IndieBio.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available